A ncuroblastoma X glioma hybrid cell line with morphine receptors has been described (1). The receptors are stereospecific with respect to narcotic binding, and receptor affinities for narcotics closely rcscmble those of rat brain (2-4) and correlate well with their pharmacologic potencies. Collier and Roy have reported that prostaglandin E dependent CAMP synthesis is inhibited by narcotics in rat brain homogenates (5, 6) . In this communication the effects of morphine and other narcotics upon adenylate cyclase [EC 4.6.1.1; ATP pyrophosphate-lyase (cyclizing)] activity of neuroblastoma X glioma hybrids and parental cells are examined. We find that morphine and other narcotics inhibit adenylate cyclase activity and that the inhibition is dependent upon morphine receptors.
MATERIALS AND METHODS
JIalerials. [G-'H]Naloxone (26.3 Ci/mmol) and were from New England Nuclear; [(u-~*I']ATI (6-10 Ci/mmol) was from ICN; and [t'-"Cl-CAMP (0.295 Ci/mmol) was from Amersham/Searle.
Morphinc sulfate was from Merck; naloxone.HCl was a gift of Endo Labs; etorphine was from Dr. R. Willette, NIDA; other narcotics were from Dr. Everette May; FGEr was from Dr. John Pike, Upjohn Co.; Ro20-1724 [4-(3-butosy-4-methosybenzyl)-2-imidazolidinone was from Hoffman LaRoche; IHMX (3-isobutyl-1-methylxanthine) was from rlldrich; Gpp(NH)p (5'-guanylylimidodiphosphate) was from ICN; cAAll', crcatine phosphate, and creatine kinase (155 U/mg of protein) were from Sigma.
Cell Lines. Neuroblastoma X glioma hybrid NGlOS-15 was obtained5 by fusion of mouse neuroblastoma clone N18TG-2 Abbreviations: Ro29-1724,4-(3-butoxy-4-met.hoxybenzy1)-2-imidazolidinone;
IBMX, 3-isobutyl-1-methylxanthine; GPP-(NH)p, 5'-guanylylimidodiphosphate; PGE,, prostaglandin EI. t Fogarty International Fellow, on leave from the Department of Biochemistry, All India Institute of Medical Sciences, New I)elhi, India. 5 B. Hamprecht, T. Amano, and M. Nirenberg, in preparation.
(7) and rat glioma clone C6BC-1 (8), derived from C6 (9). Cells were grown as described (1).
Assay of cAJlP of In&l
Cells. Confluent cells (3-4 mg of protein 60 min dish) were washed 3 times with 5 ml of medium A [Dulbecco's modified Eagle's medium with 25 mM Hepes (N-2-hydroxyethylpiperazine-N'2-ethanesulfonic acid) pH 7.4, instead of NaHCOa, adjusted to 340 mosmol/liter with 1.1 g of NaCl/liter] and incubated with medium A plus 0.5 mM Ro20-1724 and 0.5 mM 1BMX for 30 min at 37". Reactions were initiatecl by the addition of 30 ~1 of narcotic in water, 30 /II of PGE, in ethanol, or solvent. Ethanol (0.5% with Ro20-1724 present or 1% when Ro20-1724 and PGE, were present) had no effect upon CAMP formation. After incubation the medium was discarded and 3 ml of 5% trichloroacetic acid with 5 pmol of [i4C]cAM1' (3009 cpm) at 3" were added. The extract and 2 washes (each 1.5 ml of 5% trichloroacetic acid) were combined and centrifuged and the supernatant fluids applied to 0.8 X g-cm columns of AG 5OW-X4 resin, 200-400 mesh, H+ form (BioRad). The 3 ml of eluate following a 6-ml water wash was assayed for CAMP by the method of Gilman (10). Values reported arc for duplicate dishes and arc corrected to 100% recovery of c.4MP.
Adenylate
Cyclase Assay. Cells that had been washed three times were homogenized in 0.32 M sucrose, 10 mM Trisa HCL, 111I 7.4 (15 mg of protein per ml) with lo-15 strokes, by hand, of a ground-glass homogenizer. Enzyme activity was tletermined by a modification of method C of Salomon el al. (11) . Each tube contained: 45 mM Tris.HCl, pH 7.4; 5 mM MgCl,; 160 mM sucrose; 20 mM creatine phosphate; 10 U of creatine kinase; 1 mM CAMP; 0.5 m?ul Ro20-1724 (0.570 ethanol, final concentration); 1 mM [a-a21']hT1' (3 to 5 X 10' cpm) ; and 100-300 rg of homogenate protein in a final volume of 100 ~1. The reaction was terminated by addition of 50 ~1 of 157" trichloroacetic acid. For product characterization, the Y' product purified through the alumina column step (11) was subjected to Dowes-1 formate column chromat.ography. The 2 M formic acid eluate was lyophilizecl, and the radioactivity was characterized by pnper or thin-layer chromatography in: (A) isopropanol-NHIOI-I-O.1 M boric acid (7 : 1: 2) ; (B) 1 M ammonium acetate-95$& ethanol (3: 7) ; (C) isobutyric acitl-2 M NH,OH (2: 1); and (D) HIO-washed polyethyleneimine-cellulose thin-layer plates developed sequentially with HZ0 and 0.25 M LiCl. Grcatcr than 90% of the radioactivity rccovercd from the alumina columns was CAMP.
Opiate Biding.
The assay (1) was modified so that incubation mixtures contained the components of the adenylate cyclase assay and 875 rg of homogenate protein; 5 X 1Om8 M for the receptor are lower than those as measured (1) by the following factors: naloxone, 2; etorphine, 13; destrorphan, 67; levorphanol, 667; morphine, 200; and 3-allylprodinc, 100.
RESULTS
The effects of morphine upon basal and PGEi-stimulated CAMP levels in intact NGl08-15 hybrid cells and on adenylate cyclase activity in cell-free homogenates are shown in Fig. 1A and 13, respectively. The addition of PGE, to intact cells results in a 40-fold increase in intracellular CAMP levels. The addition of morphine markedly reduces cAMP levels, both in the presence and absence of PGE,. As shown in panel 13, the addition of PGEi to homogenates similarly results in a lo-fold incrcasc in adenylate cyclase activity (5-to la-fold increase in other experiments). Morphine inhibits basal and PGEidependent adenylate cyclase activity about 45yo (3@-60% inhibition in other experiments). The rate of CAMP formation was linear for about 8 min; therefore, in all subsequent experiments reaction mixtures were incubated for 5 min.
The effect of morphine upon adenylate cyclase activity was verified in the following ways: (i) the [arP]product of the reaction was shown to have the chromatographic mobility of authentic CAMP in five systems (see Jfateriala and Melhods) ; (ii) the concentration of substrate, ATP, did not change appreciably during incubation by direct measurement with the luciferase assay (12) ; and. (iii) the specific activity of ATP changed less than 5% during the incubation.
The effect of naloxone, an antagonist that displaces morphine from the opiate receptor but has no narcotic activity, is shown in Table 1 . Naloxone reverses the inhibitory effect of morphine upon adenylate cyclase activity both in the prcscnce and absence of PGE,, but naloxone alone has little or no effect upon basal or PGE,-stimulated adcnylate cyclase activity.
The relation between molarity of PGEi and the specific activity of adenylate cyclase is shown in Fig. 2 . Adenylate cyclase is stimulated by concentrations of PGEI greater than 10e8 M. A discontinuity in the concentration curve is observed at 5 x lo-' M PGEI.
The effects of different concentrations of naloxone, in the presence and absence of morphine, on adenylate cyclase are shown in Fig. 3 . The concentration of morphine was lo+ M, which inhibits adenylate cyclase activity maximally. Naloxone completely reverses the inhibitory effect of morphine on adenylate cyclase activity at 2 X 10ee5 M; naloxone at higher concentrations stimulates adenylate cyclase activity 15-20~o. Stimulation has not been observed in all experiments, and further experiments are needed to clarify this observation.
In Fig. 4 the decrease in binding of ['Hlnaloxonc to the narcotic receptor, as a function of narcotic concentration, is compared with the effectiveness of the narcotics as inhibitors of adenylate cyclase activity. Naloxone, a pure antagonist, binds with high affinity to the opiate receptor but does not inhibit adenylate cyclsse activity (panel A). Etorphine, levorphanol, morphine, and 3-allylprodine, each a potent narcotic, inhibit adcnylate cyclasc at essentially the same concentrations as those needed to displace [SH] naloxone from the opiate receptor (panels 13, C, E, and F). In contrast to levorphanol, the analgesically inactive enantiomer dextrorphan is without effect on adenylate cyclase activity and has a much lower affinity for the opiate receptor (panel D).
Apparent dissociation constants for [narcotic. opiate receptor] complexes are shown in Table 2 , along with apparent K, values for adenylate cyclase calculated from the data of Fig. 4 . A striking similarity is observed between the dissociation constants and the concentrations of narcotics required for 50% inhibition of adenylate cyclase activity.
Narcotic binding and enzyme inhibition curves shown in Fig. 4 are not superimposable, even though the narcotic concentrations for half-maximal inhibition of binding and enzyme activity agree well. With each of the four narcotics, enzyme activity changes over a relatively small range of narcotic concentration compared to narcotic binding. This relationship is seen more clearly in Fig. 5A and B, which shows Hill plots of narcotic binding and adenylate cyclase inhibition, respectively. Each slope for narcotic binding is approximately 1, whereas the maximum slopes for adenylate cyclase inhibition are 2.3. These results suggest that the binding of narcotics to receptors is not a cooperative process, w!jereas the effects of narcotics on adenylate cyclase activity exhibit a cooperative character.
The relation between the molarity of Gpp(NH)p, a rela.-tively stable analog of GTP, and adenylate cyclase activity, in the presence and absence of morphine, is shown in Fig. 6 . 3-Allylprodine 10,000 50,000 Dextrorphan 10,000 -Naloxone 20 -* Apparent dissociation constant of the narcotic-receptor complex.
t Narcotic concentrat.ion required for 50V0 of maximal inhibition of adenylate cyclase.
-, no inhibition. 
Gpp(NH)p.
In the absence of morphine, <1 X 1O-6 M Gpp-(NH)p has little effect upon adenylate cyclase activity. Similar results were obtained with partially purified membrane preparations (not shown).
The effects of morphine upon adenylate cyclase activity of intact neuroblastoma N18TG-2 and glioma @UU-1 cells, the parents of hybrid NGlOB-i5, are shown in Fig. 7A and B, respectively.
Morphine reduces CAMP levels of neuroblastoma N18TG-2 cells slightly but does not affect CAMP levels of glioma C6BU-1 cells.
The effects of morphine and naloxone upon adenylate cyclase activity of homogenates prepared from parent neuroblastoma N18TG-2 and glioma C6BU-1 cells are shown in Table 3 . Morphine inhibits adenylate cyclase activity of N18TG-2 slightly, and the inhibition is reversed by naloxone; however, these compounds do not affect adenylate cyclase activity of CGBU-I. Thus, the neuroblastoma parent, which has few morphine receptors, a is slightly sensitive to morphine whereas the glioma parent, which lacks these receptors, is insensitive to morphine.
DISCUSSION
shows no specific binding of either naloxone or di.hydromorphine.
The results show that morphine reduces basal and PGE1-stimulated CAMP levels of intact neuroblastoma X glioma hybrid cells and inhibits adenylate cyclase activity of homogenates. The effects of morphine are blocked by the narcotic antagonist, naloxone, which competes with narcotics for sites on the opiate receptor. The' inhibition of adenylate cyclase activity by narcotics is specific for the levorotatory, pharmacologically active, stereoisomer. The relative affinities of narcotics for the opiate receptor agree well with their effectiveness as inhibitors of adenylate cyclase and with their pharmacologic potency. Morphine-sensitive and -insensitive cell lines g Neuroblastoma clone N18TG-2 can be shown to have a relatively small number of morphine receptors when binding experiments are performed with ["Hjnaloxone in place of the ['HIdihydromorphine used previously (1). Glioma clone CGBU-1 were found, and the degree of sensitivity to morphine is dependent upoh the abundance of narcotic receptors. Thus, two kinds of adenylate cyclase complex were detected, one sensitive, the other insensitive, to narcotics. Sensitivity to narcotics is dependent upon functional interaction of the [morphine.reccptor] complex with adenylate cyclase. The partial inhibition of adenylate cyclase observed in the presence of saturating concentrations of narcotics may be due, at least in part, to the presence of narcotic-sensitive and -insensitive adenylate cyclase molecules within cells and, possibly, heterogeneity in the cell population with respect to the number of narcotic receptors per cell.
Interactions that couple morphine receptors with adenylate cyclase exhibit positive cooperativity ; however, the interaction of narcotic with receptor is not a cooperative process. The Hill coefficient of 2.3 suggests that multiple interactions between [narcotic.receptor] and the adenylate cyclase complex may be required for inhibition. Alternate mechanisms for apparent cooperativity may be envisaged involving threshold effects and spare receptors. The cooperative activation of adenylate cyclase has been reported for thyroid stimulating hormone (14), but glucagon (15) and oxytociu (16) Reactions that terminate reading of messages by adenylate cyclase regulate the duration of response of the enzyme to each message. GTP may be involved both in initiation and termination of reading of hormonal messages by adenylate cyclase-in ways that may be analogous to the roles of GTP in aminoacyl-tRNh binding to ribosomes and translocation reactions in protein synthesis.
The GTP analog, Gpp(NH)p, activates adenylate cyclase, and morphine reduces the threshold for activation lo-fold. Thus morphine and Gpp(NH)p act in a concerted fashion, which suggests that both are physically coupled to the adenylate cyclase complex. The K, for glucagon stimulation of adenylate cyclase is reduced lo-fold by GTP (24). The possibility that GTP is required for morphine action, as it is for hormone action, should be considered.
Collier and Roy have presented cogent arguments supporting the thesis that PGE-stimulated adenylate cyclase is the primary site of morphine action (5, 6). Our results support their view, although we find that morphine inhibits adenylate cyclase both in the presence and absence of added PGEi. The inhibition of adenylate cyclase should have many secondary consequences which might account for the varied pharmacologic effects of morphine.
We wish to propose the following hypothesis concerning the molecular basis for narcotic addiction and tolerance. Inhibition of adenylate cyclase by morphine reduces intracellular levels of CAMP. This may lead to a compensatory shift in enzyme synthesis, degradation, or activity which restores the normal level of CAMP. The cell then is dependent upon narcotic because the level of &Ml' is normal in the presence of the drug and abnormally high upon withdrawal. Our working hypothesis is that the number of adenylate cyclase molecules increases as cells become addicted to narcotics. This also leads to tolerance since, at a given narcotic concentration, the amount of uninhibited enzyme is greater in addicted than in normal cells.
